News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ANI Pharmaceuticals, Inc. Reports Record Net Revenues Of $10.5 million, EPS From Continuing Operations Of $0.35, And Adjusted Non-GAAP EBITDA Of $3.9 Million For The Fourth Quarter Ended December 31, 2013


2/18/2014 8:38:57 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

BAUDETTE, Minn., Feb. 18, 2014 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (ANIP) today reported financial results for the three and twelve months ended December 31, 2013.

Fourth quarter highlights include:

•Fourth quarter record net revenues of $10.5 million, an increase of 98% as compared to $5.3 million for the same period in 2012.

Help employers find you! Check out all the jobs and post your resume.

Read at Yahoo Finance


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES